To test whether the reduced mammary tumorigenesis caused by the deletion of CCR6 was due to an effect of the CCR6-CCL20 axis on the tumor microenvironment we next investigated by flow cytometry the levels and identity of tumor-infiltrating leukocytes in mammary tumors at the stage of early carcinoma (see Fig. 1a). This evidence concerns the gene CCL20 and carcinoma.